QIAGEN N.V. announced it has joined CANCER-ID, a public-private consortium aiming to establish standard protocols and clinical validation for blood-based biomarkers in lung and breast cancer. Rapid advances in the use of liquid biopsies, which enable cancer treatment and monitoring through ... more
QIAGEN expands access to state-of-the-art HPV screening in China through co-marketing agreement with KingMed DiagnosticsAgreement will make HPV testing more widely available throughout China
QIAGEN N.V. announced that it will expand access to its digene HPV Test across China through a co-marketing agreement with KingMed Diagnostics. Through the agreement, KingMed Diagnostics will function as a centralized lab, allowing smaller hospitals and those in less-populated areas to offer the digene HPV Test and send samples to KingMed Diagnostics for processing and analysis. The agreement is an additional milestone for QIAGEN’s molecular diagnostics franchise in China and its focus on driving growth in emerging markets. The digene HPV Test was first registered in China in 2000 and is now widely available in many of the country’s top-tier hospitals and private labs.
- diagnostic tests
QIAGEN N.V. announced that it has expanded its relationship with BG to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing data generated from their sam ... more
QIAGEN N.V. announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential to driving the adoption of Next-Generation Sequencing (NGS) and other genetic analysis technologies in life sciences resear ... more
- analytica Vietnam on a growth course
- Eurofins acquires environmental testing laboratory business of Ramboll Group ...
- Sartorius acquires software company Umetrics and
- Signaling Continued Investment in China, Bruker Open Beijing Center of Excel ...
- Carl Zeiss Meditec AG wins patent infringement action on trifocal intraocula ...